What is agentic AI, and can it help accelerate scientific discovery? In a Q&A, Stanford Medicine researcher James Zou explains how AI can act independently to help researchers ideate, hypothesize and accelerate scientific discovery. https://t.co/9ECSCOi3dt
Agentic AI in biomedical research: What is it and can it expedite science? med.stanford.edu
AI Weekly's analysis
→
- Stanford's James Zou now uses AI agents across nearly every stage of his lab's research, from refining project ideas to reviewing manuscripts.
- His group runs a virtual laboratory, a virtual biotech investigating drug targets, and Paper2Agent, which turns individual manuscripts into queryable agents.
- Zou cautions that agents still make mistakes and cannot yet act in the physical world, so real-lab validation stays essential.
Read full analysis →
Stanford Medicine researchers have converted scientific papers into artificial intelligence agents that can answer questions, run analyses and collaborate to make new discoveries. https://t.co/HjDnhRbYVY https://t.co/NULlppqPAF
Manuscripts-turned AI agents can now ‘talk’ to each other, make new discoveries stan.md
Stanford Medicine researchers have converted scientific papers into artificial intelligence agents that can answer questions, run analyses and collaborate to make new discoveries. https://t.co/HjDnhRbYVY https://t.co/NULlppqPAF
Manuscripts-turned AI agents can now ‘talk’ to each other, make new discoveries med.stanford.edu
AI Weekly's analysis
→
- Stanford Medicine built Paper2Agent, a system that converts scientific manuscripts into interactive AI agents that reproduce research and answer questions.
- In a demonstration, two agents from unrelated studies surfaced a molecular variant near the gene MPHOSPH9 tied to increased ADHD risk.
- The team, led by Jiacheng Miao and James Zou, has built more than 100 agents and published the work in Nature on September 16, 2026.
Read full analysis →
